Autres langues Realcan Pharmaceutical Group Co., Ltd.

Actions

002589

CNE1000013X5

Produits pharmaceutiques

Cours en clôture Shenzhen S.E. 16/09/2026			Varia. 5j.	Varia. 1 janv.
2,950 ^CNY	+0,34%		-8,67%	-8,39%

20/08	Realcan Pharmaceutical Group Co., Ltd. approuve l'élection de Lv Kaiqiang et Wu Bin en tant qu'administrateurs indépendants	CI
20/08	Realcan Pharmaceutical Group Co., Ltd. publie ses résultats pour le semestre clos le 30 juin 2026	CI

Autres langues

20/08	Realcan Pharmaceutical Group Co., Ltd. Approves the Election of Lv Kaiqiang and Wu Bin as Independent Director
20/08	Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026
19/05	Realcan Pharmaceutical Group Co., Ltd. Approves Cash Dividend for 2025 for A shares, Payable on 30 June 2026
24/04	Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026
23/04	Realcan Pharmaceutical Group Co., Ltd. announces Annual dividend, payable on June 30, 2026
22/04	Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025
07/11	Tranche Update on Realcan Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on November 11, 2024.
07/11	Realcan Pharmaceutical Group Co., Ltd.'s Equity Buyback announced on November 11, 2024, has closed with 34,638,659 shares, representing 2.31% for CNY 101.48 million.
29/10/25	Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025
13/10/25	Tranche Update on Realcan Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on November 11, 2024.
25/08/25	Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025
03/07/25	Realcan Pharmaceutical Vice President Detained
03/07/25	Tranche Update on Realcan Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on November 11, 2024.
03/06/25	Yanquan No. 8 Private Securities Investment Fund, a fund managed by Jiaxing Yanquan Investment Partnership LLP cancelled the acquisition of 5.05% stake in Realcan Pharmaceutical Group Co., Ltd. from Zhang Renhua for approximately CNY 160 million.
03/06/25	Realcan Pharmaceutical Group Shareholder Nixes Share Transfer Deal
19/05/25	Realcan Pharmaceutical Group Co., Ltd. Approves Cash Dividend for 2024
16/05/25	Declaration of Voting Results by Realcan Pharmaceutical Group
06/05/25	Realcan Pharmaceutical Group Receives Shareholder Proposal from Renhua Zhang
29/04/25	Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025
24/04/25	Realcan Proposes Final Cash Dividend for 2024
23/04/25	Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024
08/04/25	Tranche Update on Realcan Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on November 11, 2024.
07/04/25	Realcan Pharmaceutical Releases Correction on Auditor's Penalties; Shares Slump 10%
24/02/25	Realcan Pharmaceutical to Buy Majority Stake in First-Class Medical Device Maker for 151 Million Yuan
09/01/25	Tranche Update on Realcan Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on November 11, 2024.